Multidimensional Proteomics Analysis of Amniotic Fluid to Provide Insight into the Mechanisms of Idiopathic Preterm Birth

Background Though recent advancement in proteomics has provided a novel perspective on several distinct pathogenetic mechanisms leading to preterm birth (inflammation, bleeding), the etiology of most preterm births still remains elusive. We conducted a multidimensional proteomic analysis of the amniotic fluid to identify pathways related to preterm birth in the absence of inflammation or bleeding. Methodology/Principal Findings A proteomic fingerprint was generated from fresh amniotic fluid using surface-enhanced laser desorbtion ionization time of flight (SELDI-TOF) mass spectrometry in a total of 286 consecutive samples retrieved from women who presented with signs or symptoms of preterm labor or preterm premature rupture of the membranes. Inflammation and/or bleeding proteomic patterns were detected in 32% (92/286) of the SELDI tracings. In the remaining tracings, a hierarchical algorithm was applied based on descriptors quantifying similarity/dissimilarity among proteomic fingerprints. This allowed identification of a novel profile (Q-profile) based on the presence of 5 SELDI peaks in the 10–12.5 kDa mass area. Women displaying the Q-profile (mean±SD, gestational age: 25±4 weeks, n = 40) were more likely to deliver preterm despite expectant management in the context of intact membranes and normal amniotic fluid clinical results. Utilizing identification-centered proteomics techniques (fluorescence two-dimensional differential gel electrophoresis, robotic tryptic digestion and mass spectrometry) coupled with Protein ANalysis THrough Evolutionary Relationships (PANTHER) ontological classifications, we determined that in amniotic fluids with Q-profile the differentially expressed proteins are primarily involved in non-inflammatory biological processes such as protein metabolism, signal transduction and transport. Conclusion/Significance Proteomic profiling of amniotic fluid coupled with non-hierarchical bioinformatics algorithms identified a subgroup of patients at risk for preterm birth in the absence of intra-amniotic inflammation or bleeding, suggesting a novel pathogenetic pathway leading to preterm birth. The altered proteins may offer opportunities for therapeutical intervention and future drug development to prevent prematurity.

[1]  J. Martin,et al.  Births: final data for 2005. , 2007, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[2]  György Marko-Varga,et al.  Personalized medicine and proteomics: lessons from non-small cell lung cancer. , 2007, Journal of proteome research.

[3]  Leonardo Pereira,et al.  Comprehensive proteomic analysis of the human amniotic fluid proteome: gestational age-dependent changes. , 2007, Journal of proteome research.

[4]  V. Bhandari,et al.  Proteomic Biomarkers of Intra-amniotic Inflammation: Relationship with Funisitis and Early-onset Sepsis in the Premature Neonate , 2007, Pediatric Research.

[5]  V. Bhandari,et al.  Proteomic Profiling of the Amniotic Fluid to Detect Inflammation, Infection, and Neonatal Sepsis , 2007, PLoS medicine.

[6]  Nan Guo,et al.  PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways , 2006, Nucleic Acids Res..

[7]  M. Purwar,et al.  Causes of stillbirths and early neonatal deaths: data from 7993 pregnancies in six developing countries. , 2006, Bulletin of the World Health Organization.

[8]  C. Weiner,et al.  Clinical Proteomics: A Novel Diagnostic Tool for the New Biology of Preterm Labor, Part I: Proteomics Tools , 2006, Obstetrical & gynecological survey.

[9]  C. Weiner,et al.  Proteomic biomarkers that predict the clinical success of rescue cerclage. , 2005, American journal of obstetrics and gynecology.

[10]  C. Buhimschi,et al.  Proteomic biomarker analysis of amniotic fluid for identification of intra‐amniotic inflammation , 2005, BJOG : an international journal of obstetrics and gynaecology.

[11]  B. Vohr,et al.  Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. , 2004, JAMA.

[12]  H. Matsuzaki,et al.  Bikunin Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor Alpha Induction in Macrophages , 2004, Clinical Diagnostic Laboratory Immunology.

[13]  N. Vij,et al.  Lumican suppresses cell proliferation and aids Fas-Fas ligand mediated apoptosis: implications in the cornea. , 2004, Experimental eye research.

[14]  J. Martin,et al.  Births: final data for 2002. , 2003, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[15]  C. Lockwood Testing for risk of preterm delivery. , 2003, Clinics in laboratory medicine.

[16]  J. Moutquin Classification and heterogeneity of preterm birth , 2003, BJOG : an international journal of obstetrics and gynaecology.

[17]  M. Suzuki,et al.  The Protease Inhibitor Bikunin, a Novel Anti-Metastatic Agent , 2003, Biological chemistry.

[18]  K. Volz,et al.  Pigment Epithelium-Derived Factor (PEDF), a Serpin with Potent Anti-Angiogenic and Neurite Outgrowth-promoting Properties , 2002, Biological chemistry.

[19]  Emanuel F. Petricoin,et al.  Clinical Applications of Proteomics: Proteomic Pattern Diagnostics , 2002, Journal of Mammary Gland Biology and Neoplasia.

[20]  L. Giudice,et al.  Hypoxia regulates insulin-like growth factor-binding protein 1 in human fetal hepatocytes in primary culture: suggestive molecular mechanisms for in utero fetal growth restriction caused by uteroplacental insufficiency. , 2001, The Journal of clinical endocrinology and metabolism.

[21]  Stark Ar 超出生体重児に対する早期デキサメサゾン投与の有用性 : National Institute of Child Health and Human Development Neonatal research Network報告 (海外誌掲載論文の和文概要とそれに対するコメント) , 2001 .

[22]  D. Sherer,et al.  Chronic Intrauterine Bleeding and Fetal Growth at Less than 32 Weeks of Gestation , 2000, Gynecologic and Obstetric Investigation.

[23]  A. Blom,et al.  Bikunin--not just a plasma proteinase inhibitor. , 2000, The international journal of biochemistry & cell biology.

[24]  H. Kobayashi,et al.  Urinary trypsin inhibitor down-regulates hyaluronic acid fragment-induced prostanoid release in cultured human amnion cells by inhibiting cyclo-oxygenase-2 expression. , 1999, Molecular human reproduction.

[25]  Terry Magnuson,et al.  Lumican Regulates Collagen Fibril Assembly: Skin Fragility and Corneal Opacity in the Absence of Lumican , 1998, The Journal of cell biology.

[26]  P. Giraudet,et al.  Insulin-Like Growth Factor Binding Protein 1 Level in Amniotic Fluid: Correlation with Birth Weight , 1998, Neonatology.

[27]  D. Clemmons,et al.  The secretion of insulin-like growth factor I, prolactin and insulin-like growth factor binding protein 1 by the decidua as predictors of human fetal growth. , 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[28]  Y. Futamura,et al.  Role of Urinary Trypsin Inhibitor in the Maintenance of Pregnancy in Mice , 1996, Obstetrics and gynecology.

[29]  T. Terao,et al.  Urinary trypsin inhibitor prevents uterine muscle contraction by inhibition of Ca++ influx. , 1995, American journal of obstetrics and gynecology.

[30]  T. Terao,et al.  Urinary trypsin inhibitor suppresses premature cervical ripening. , 1995, European journal of obstetrics, gynecology, and reproductive biology.

[31]  R. Knuppel,et al.  Amniotic fluid α1-antitrypsin concentration in premature rupture of the membranes , 1990 .

[32]  L. Silberman,et al.  The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies , 1989, Obstetrics and gynecology.

[33]  M. T. Brewer,et al.  Cloning, characterization, and expression of a human insulin-like growth factor binding protein. , 1988, Biochemical and biophysical research communications.

[34]  T. Terao,et al.  The relationship between trypsin activity in amniotic fluid and premature rupture of membranes. , 1986, American Journal of Obstetrics and Gynecology.

[35]  Kerstin,et al.  Two apparent human endothelial cell growth factors from human hepatoma cells are tumor-associated proteinase inhibitors. , 1986, The Journal of biological chemistry.

[36]  Alexey I Nesvizhskii,et al.  Protein identification by tandem mass spectrometry and sequence database searching. , 2007, Methods in molecular biology.

[37]  ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. , 2007, Obstetrics and gynecology.

[38]  J. Chambaz,et al.  Cholesterol homeostatic mechanisms in transgenic mice with altered expression of apoproteins A-I, A-II and A-IV. , 2000, International journal of tissue reactions.

[39]  Rick W. Martin,et al.  Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. , 1998, American journal of obstetrics and gynecology.

[40]  T. Terao,et al.  Effects of urinary trypsin inhibitor on myometrial contraction in term and preterm deliveries. , 1996, Gynecologic and Obstetric Investigation.

[41]  R. Leboeuf,et al.  Regulation by nutritional status of lipids and apolipoproteins A-I, A-II, and A-IV in inbred mice. , 1994, Journal of lipid research.

[42]  R. Knuppel,et al.  Amniotic fluid alpha 1-antitrypsin concentration in premature rupture of the membranes. , 1990, American Journal of Obstetrics and Gynecology.

[43]  J. Fruchart,et al.  Apolipoproteins in human amniotic fluid: concentrations, isoforms and polymorphism. , 1989, Gynecologic and Obstetric Investigation.

[44]  W. Mckeehan,et al.  Isolation of two proteinase inhibitors from human hepatoma cells that stimulate human endothelial cell growth. , 1987, Methods in Enzymology.

[45]  E. Wachter,et al.  Kunitz-type proteinase inhibitors derived by limited proteolysis of the inter-alpha-trypsin inhibitor, IV. The amino acid sequence of the human urinary trypsin inhibitor isolated by affinity chromatography. , 1981, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.